Form 4: Intuitive Surgical CEO Sells Shares

Intuitive Surgical CEO David J. Rosa exercised stock options and sold a portion of his common stock holdings under a pre-arranged trading plan.

Summary

• CEO David J. Rosa acquired 27,000 shares of Intuitive Surgical common stock by exercising non-qualified stock options at an exercise price of $79.6378 per share.
• Concurrently, Mr. Rosa sold 24,500 shares of common stock at a weighted average price of $547.5502 per share.
• These transactions were executed on October 24, 2025, as part of a Rule 10b5-1 trading plan set to expire on June 11, 2026.
• Following these transactions, Mr. Rosa directly beneficially owns 234,256 shares of common stock.

Sentiment

Score: 5

Explanation: Neutral. The transactions are routine for an executive managing equity compensation, executed under a pre-arranged 10b5-1 plan. While there's a net sale, it's not necessarily indicative of a negative outlook on the company.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and transparent approach to insider trading.
• The exercise of options suggests the executive is realizing value from previously granted equity compensation.

Negatives

• A net reduction in direct beneficial ownership by 24,500 shares (after accounting for the option exercise and sale) could be interpreted as a slight decrease in insider conviction, though common for diversification or tax purposes.

Risks

• No specific operational or financial risks to the company are mentioned. The primary risk relates to potential investor perception of insider selling, which could be interpreted negatively by some market participants.

Future Outlook

The filing does not provide forward-looking statements or guidance regarding the company's future performance, focusing solely on insider trading activity.

Management Comments

• The transactions took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 11, 2026.

Industry Context

Insider transactions like these are common across all industries, particularly for long-tenured executives who receive significant equity compensation. The medical device and surgical robotics industry, where Intuitive Surgical operates, often sees executives managing their equity holdings as part of their personal financial planning.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: May observe a slight reduction in the CEO's direct ownership, which could be interpreted in various ways, though often seen as routine for diversification or tax planning.
• Employees, Customers, Suppliers, Creditors: No direct impact from this specific filing.

Next Steps

• No specific future actions or milestones for the company are mentioned in this filing. The 10b5-1 plan will continue until its expiration on June 11, 2026.

Key Dates

Keywords

Intuitive Surgical, ISRG, David J. Rosa, Insider Trading, Form 4, Stock Option Exercise, Share Sale, CEO, 10b5-1 Plan